Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Finasteride improves prostate cancer detection in PSA test.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Early balding at 40 increases prostate cancer risk.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Male pattern baldness does not cause an increased risk of prostate cancer.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Use minoxidil for hair loss treatment, and finasteride for men.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.